46 related articles for article (PubMed ID: 24716467)
1. Molecular dynamics of interactions between rigid and flexible antifolates and dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant Plasmodium falciparum.
Mokmak W; Chunsrivirot S; Hannongbua S; Yuthavong Y; Tongsima S; Kamchonwongpaisan S
Chem Biol Drug Des; 2014 Oct; 84(4):450-61. PubMed ID: 24716467
[TBL] [Abstract][Full Text] [Related]
2. Repurposing FDA-approved drugs to target malaria through inhibition of dihydrofolate reductase in the folate biosynthesis pathway: A prospective approach.
Verma K; Chaturvedi R; Lahariya AK; Verma AK; Schneider KA; Anvikar AR; Bharti PK
J Cell Biochem; 2024 Mar; 125(3):e30533. PubMed ID: 38345373
[TBL] [Abstract][Full Text] [Related]
3. Stepwise acquisition of pyrimethamine resistance in the malaria parasite.
Lozovsky ER; Chookajorn T; Brown KM; Imwong M; Shaw PJ; Kamchonwongpaisan S; Neafsey DE; Weinreich DM; Hartl DL
Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12025-30. PubMed ID: 19587242
[TBL] [Abstract][Full Text] [Related]
4. Fitness trade-offs in the evolution of dihydrofolate reductase and drug resistance in Plasmodium falciparum.
Costanzo MS; Brown KM; Hartl DL
PLoS One; 2011; 6(5):e19636. PubMed ID: 21625425
[TBL] [Abstract][Full Text] [Related]
5. In silico ADMET study, docking, synthesis and antimalarial evaluation of thiazole-1,3,5-triazine derivatives as Pf-DHFR inhibitor.
Sahu S; Ghosh SK; Gahtori P; Pratap Singh U; Bhattacharyya DR; Bhat HR
Pharmacol Rep; 2019 Oct; 71(5):762-767. PubMed ID: 31351317
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis confirms the presence of distal inhibitor-selectivity determining residues in B. stearothermophilus dihydrofolate reductase.
Eck T; Patel S; Candela T; Leon H K; Little M; Reis NE; Liyanagunawardana U; Gubler U; Janson CA; Catalano J; Goodey NM
Arch Biochem Biophys; 2020 Oct; 692():108545. PubMed ID: 32810476
[TBL] [Abstract][Full Text] [Related]
7. Molecular Docking Analysis of Pyrimethamine Derivatives with Plasmodium falciparum Dihydrofolate Reductase.
Singh IV; Mishra S
Bioinformation; 2018; 14(5):232-235. PubMed ID: 30108420
[TBL] [Abstract][Full Text] [Related]
8. Investigating the anti-cancer potential of pyrimethamine analogues through a modern chemical biology lens.
Brown JI; Persaud R; Iliev P; Karmacharya U; Attarha S; Sahile H; Olsen JE; Hanke D; Idowu T; Frank DA; Frankel A; Williams KC; Page BDG
Eur J Med Chem; 2024 Jan; 264():115971. PubMed ID: 38071795
[TBL] [Abstract][Full Text] [Related]
9. Discovery of rigid biphenyl
Hoarau M; Sermmai P; Varatthan T; Thiabma R; Jantra T; Rattanajak R; Vitsupakorn D; Vanichtanankul J; Saepua S; Yuthavong Y; Thongpanchang C; Kamchonwongpaisan S
RSC Med Chem; 2023 Sep; 14(9):1755-1766. PubMed ID: 37731689
[No Abstract] [Full Text] [Related]
10. Oplodiol and nitidine as potential inhibitors of
Akakpo L; Gasu EN; Mensah JO; Borquaye LS
J Biomol Struct Dyn; 2024; 42(4):1655-1669. PubMed ID: 37194452
[TBL] [Abstract][Full Text] [Related]
11. The antimicrobial drug pyrimethamine inhibits STAT3 transcriptional activity by targeting the enzyme dihydrofolate reductase.
Heppler LN; Attarha S; Persaud R; Brown JI; Wang P; Petrova B; Tošić I; Burton FB; Flamand Y; Walker SR; Yeh JE; Zubarev RA; Gaetani M; Kanarek N; Page BDG; Frank DA
J Biol Chem; 2022 Feb; 298(2):101531. PubMed ID: 34953855
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel peptide inhibitors of
Devi K; Chandra A; Kumar V; Othayoth J; Rathi B; Goel VK
J Biomol Struct Dyn; 2024 Apr; ():1-11. PubMed ID: 38686916
[TBL] [Abstract][Full Text] [Related]
13. Origin of robustness in generating drug-resistant malaria parasites.
Kümpornsin K; Modchang C; Heinberg A; Ekland EH; Jirawatcharadech P; Chobson P; Suwanakitti N; Chaotheing S; Wilairat P; Deitsch KW; Kamchonwongpaisan S; Fidock DA; Kirkman LA; Yuthavong Y; Chookajorn T
Mol Biol Evol; 2014 Jul; 31(7):1649-60. PubMed ID: 24739308
[TBL] [Abstract][Full Text] [Related]
14. Computational redesign of Beta-27 Fab with substantially better predicted binding affinity to the SARS-CoV-2 Omicron variant than human ACE2 receptor.
Treewattanawong W; Sitthiyotha T; Chunsrivirot S
Sci Rep; 2023 Sep; 13(1):15476. PubMed ID: 37726329
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and ligand binding properties of recombinant
Deetanya P; Sitthiyotha T; Chomanee N; Chunsrivirot S; Wangkanont K
Heliyon; 2022 Aug; 8(8):e10396. PubMed ID: 36061023
[TBL] [Abstract][Full Text] [Related]
16. Computational design of Lactobacillus Acidophilus α-L-rhamnosidase to increase its structural stability.
Sitthiyotha T; Klaewkla M; Krusong K; Pichyangkura R; Chunsrivirot S
PLoS One; 2022; 17(5):e0268953. PubMed ID: 35613129
[TBL] [Abstract][Full Text] [Related]
17. Computational redesign of Fab CC12.3 with substantially better predicted binding affinity to SARS-CoV-2 than human ACE2 receptor.
Treewattanawong W; Sitthiyotha T; Chunsrivirot S
Sci Rep; 2021 Nov; 11(1):22202. PubMed ID: 34772947
[TBL] [Abstract][Full Text] [Related]
18. Global diversity of the gene encoding the Pfs25 protein-a Plasmodium falciparum transmission-blocking vaccine candidate.
Sookpongthai P; Utayopas K; Sitthiyotha T; Pengsakul T; Kaewthamasorn M; Wangkanont K; Harnyuttanakorn P; Chunsrivirot S; Pattaradilokrat S
Parasit Vectors; 2021 Nov; 14(1):571. PubMed ID: 34749796
[TBL] [Abstract][Full Text] [Related]
19. Computational design of SARS-CoV-2 peptide binders with better predicted binding affinities than human ACE2 receptor.
Sitthiyotha T; Chunsrivirot S
Sci Rep; 2021 Aug; 11(1):15650. PubMed ID: 34341401
[TBL] [Abstract][Full Text] [Related]
20. Unravelling Regioselectivity of
Wangpaiboon K; Sitthiyotha T; Chunsrivirot S; Charoenwongpaiboon T; Pichyangkura R
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33810084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
